Urology Times staff
New Urology Products & Services
The newest urology products and services from Astellas Pharma US, Inc., Ethicon Endo-Surgery, Inc., Poiesis Medical, and Verathon Inc.
Pediatric urologists top list of those with long wait times
A new national survey shows severe physician shortages among certain pediatric specialties, and pediatric urologists top the list of those registering long wait times for pediatric surgical care.
Genetic test may reduce need for repeat prostate biopsy
A recently developed genetic test to predict a man's risk for prostate cancer could reduce the need for repeat biopsies in men who have had a negative biopsy, data from a new study indicate.
Dr. Levin joins large Mid-Atlantic practice
R.D. Levin, MD, has joined Chesapeake Urology Associates and will see patients in the practice's Pine Heights Medical Center and Maple Lawn/Columbia offices in Maryland.
New Urology Products & Services
The newest urology products and services from Covidien, Beckman Coulter, Inc., Allergan Inc., the Seattle App Lab, and Griffin Technology.
East Coast insurer now covers tibial nerve stimulation for OAB
Uroplasty, Inc. has announced that EmblemHealth now covers percutaneous tibial nerve stimulation using the company's Urgent PC Neuromodulation System for the treatment of overactive bladder and associated symptoms.
Study: Many men with prostate cancer can avoid early surgery
Many men with prostate cancer do not need immediate treatment, especially if they have low PSA scores or low-risk tumors that are unlikely to grow and spread, according to a multicenter study that suggests such men who undergo radical prostatectomy fare no better than those undergoing observation.
Incontinence may be common, underreported in young women
Urinary incontinence may be a common problem among young women who have never been pregnant, according to a study in the Annals of Internal Medicine.
Imaging cuts in proposed Medicare rule potentially dangerous, radiologists say
Extreme cuts to funding for medical imaging scans in the Medicare fee schedule proposed rule for 2013 are unnecessary, unfounded, and undermine care for the most sick or injure seniors, according to the American College of Radiology.
Oncologists, osteopaths show support for prostate cancer screening
Physicians should discuss the benefits and risks of PSA testing with their asymptomatic male patients who have life expectancies of greater than 10 years, but the risks outweigh the benefits of men with shorter life expectancies, according to a new evidence-based provisional clinical opinion on prostate cancer screening issued by the American Society of Clinical Oncology.

Poll

View Results